Germany's MediClin 2025 revenue rises on post-acute segment growth

MEDICLIN AG

27/03/2026 08:48

Overview

Germany healthcare provider's 2025 revenue grew 4.8% yr/yr, treating 1% more inpatients

Group EBIT for 2025 rose 3.5% yr/yr

Company expects 2026 revenue growth of 3.5%-6.5% and higher EBIT

Outlook

MediClin expects 2026 revenue growth of 3.5% to 6.5%

Company sees 2026 group EBIT between EUR 57.0 mln and EUR 72.0 mln

Management board cites solid operational capacity utilisation for 2026 outlook

Result Drivers

POST-ACUTE GROWTH - Revenue and operating profit in the post-acute segment rose, driven by higher earnings and supported by strategic measures, per management

STABLE OCCUPANCY - Stable occupancy rates at facilities supported operational performance, according to COO Thomas Piefke

ACUTE CARE DIVESTMENT - Revenue in the acute care segment fell mainly due to the sale of the former MEDICLIN Heart Centre Coswig

Company press release: ID:nEQ8jGK0ka

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
FY Sales
Slight Beat*
EUR 784.50 mln
EUR 782.40 mln (1 Analyst)
FY EBIT
EUR 55.40 mln


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)